252 related articles for article (PubMed ID: 6770605)
1. Inhibition of arachidonate metabolism by selected compounds in vitro with particular emphasis on the thromboxane A2 synthase pathway.
Tobias LD; Hamilton JG
Adv Prostaglandin Thromboxane Res; 1980; 6():453-6. PubMed ID: 6770605
[No Abstract] [Full Text] [Related]
2. [Suppression of platelet aggregation as a result of two-component inhibition of a polyenzyme system of thromboxane synthesis].
Varfolomeev SD; Lakin KM; Mevkh AT; Novikova NV; Rukazenkov IuZ
Dokl Akad Nauk SSSR; 1985; 282(1):194-6. PubMed ID: 3928305
[No Abstract] [Full Text] [Related]
3. Imidazo[1,5-a]pyridines: a new class of thromboxane A2 synthetase inhibitors.
Ford NF; Browne LJ; Campbell T; Gemenden C; Goldstein R; Gude C; Wasley JW
J Med Chem; 1985 Feb; 28(2):164-70. PubMed ID: 3918169
[TBL] [Abstract][Full Text] [Related]
4. [Effect of thromboxane synthetase inhibitors on the action of bronchoactive agents and on arachidonate metabolism in the guinea pig tracheobronchopulmonary system].
Kitamura S; Ishihara Y; Takaku F
Nihon Kyobu Shikkan Gakkai Zasshi; 1984 Jan; 22(1):3-8. PubMed ID: 6539836
[No Abstract] [Full Text] [Related]
5. Biosynthesis of thromboxanes.
Hammarström S; Diczfalusy U
Adv Prostaglandin Thromboxane Res; 1980; 6():267-74. PubMed ID: 6770598
[No Abstract] [Full Text] [Related]
6. Reversible inhibition of thromboxane A2 production by imidazole 2-hydroxybenzoate (ITF 182) in the arachidonic acid injected rat. A comparison with acetylsalicylic acid and indometacin.
Pagella PG; Agozzino S; Bellavite O; Donà GC
Arzneimittelforschung; 1984; 34(5):597-8. PubMed ID: 6432000
[TBL] [Abstract][Full Text] [Related]
7. Selective blockade of thromboxane A2 synthesis during experimental E coli bacteremia in the goat. Effects on hemodynamics and lung water.
Harlan J; Winn R; Weaver J; Hildebrandt J; Harker L
Chest; 1983 May; 83(5 Suppl):75S-76S. PubMed ID: 6340988
[No Abstract] [Full Text] [Related]
8. Pharmacology of thromboxane synthetase inhibitors.
Aiken JW
Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():253-8. PubMed ID: 6221532
[No Abstract] [Full Text] [Related]
9. Biology and biochemistry of thromboxane synthetase inhibitors.
Gorman RR
Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():235-40. PubMed ID: 6221529
[No Abstract] [Full Text] [Related]
10. Inhibition of thromboxane A2 biosynthesis in human platelets by burimamide.
Allan G; Eakins KE; Kulkarni PS; Levi R
Br J Pharmacol; 1980; 71(1):157-64. PubMed ID: 6781572
[TBL] [Abstract][Full Text] [Related]
11. Thromboxane a2: biosynthesis and effects on platelets.
Granström E; Diczfalusy U; Hamberg M; Hansson G; Malmsten C; Samuelsson B
Adv Prostaglandin Thromboxane Leukot Res; 1982; 10():15-58. PubMed ID: 6216781
[No Abstract] [Full Text] [Related]
12. Inhibition of platelet aggregation by 1-alkylimidazole derivatives, thromboxane A synthetase inhibitors.
Kayama N; Sakaguchi K; Kaneko S; Kubota T; Fukuzawa T; Kawamura S; Yoshimoto T; Yamamoto S
Prostaglandins; 1981 Apr; 21(4):543-54. PubMed ID: 7196056
[TBL] [Abstract][Full Text] [Related]
13. Determination of the effects of inhibition of pulmonary thromboxane A2 synthase activity, in vivo and in vitro.
McNamara DB; Kerstein MD; Harrington JK; Bellan JA; Graybar GB; Hyman AL; Kadowitz PJ
Adv Prostaglandin Thromboxane Leukot Res; 1989; 19():531-4. PubMed ID: 2526532
[No Abstract] [Full Text] [Related]
14. On the inhibitory potency of imidazole and its derivatives on thromboxane synthetase.
Tai HH; Yuan B
Biochem Biophys Res Commun; 1978 Jan; 80(1):236-42. PubMed ID: 623654
[No Abstract] [Full Text] [Related]
15. Effects of selective inhibition of thromboxane synthesis on renal function in humans.
Zipser RD
Am J Physiol; 1985 Jun; 248(6 Pt 2):F753-6. PubMed ID: 3839111
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of human platelet thromboxane synthetase by 11a-carbathromboxane A2 analogs.
Gorman RR; Maxey KM; Bundy GL
Biochem Biophys Res Commun; 1981 May; 100(1):184-90. PubMed ID: 7196228
[No Abstract] [Full Text] [Related]
17. Inhibition of thromboxane synthesis and platelet aggregation by pyridine and its derivatives.
Tai HH; Lee N; Tai CL
Adv Prostaglandin Thromboxane Res; 1980; 6():447-52. PubMed ID: 7189951
[TBL] [Abstract][Full Text] [Related]
18. Biochemical and pharmacological evaluation of thromboxane synthetase inhibitors.
Gorman RR
Adv Prostaglandin Thromboxane Res; 1980; 6():417-25. PubMed ID: 6247892
[No Abstract] [Full Text] [Related]
19. Pharmacology and endogenous roles of prostaglandin endoperoxides, thromboxane A2, and prostacyclin.
Moncada S; Vane JR
Pharmacol Rev; 1978 Sep; 30(3):293-331. PubMed ID: 116251
[No Abstract] [Full Text] [Related]
20. Inhibition of platelet thromboxane A2 synthase activity by sodium 5-(3'-pyridinylmethyl)benzofuran-2-carboxylate.
Gorman RR; Johnson RA; Spilman CH; Aiken JW
Prostaglandins; 1983 Aug; 26(2):325-42. PubMed ID: 6316421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
